William Palo

Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout

Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann et al. · New England Journal of Medicine · 2005 · 1.3K citations · Full text

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty‐eight–day, multicenter, phase II, randomized, double‐blind, placebo‐controlled, dose‐response clinical trial examining safety and efficacy in patients with gout

Michael A. Becker, H. Ralph Schumacher, Robert L. Wortmann et al. · Arthritis & Rheumatism · 2005 · 267 citations

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

David S. Baldwin, Lambros Chrones, Ioana Florea et al. · Journal of Psychopharmacology · 2016 · 182 citations · Full text

Magnetic resonance imaging in the quantitative assessment of gouty tophi

H. Ralph Schumacher, Michael A. Becker, N. Lawrence Edwards et al. · International Journal of Clinical Practice · 2006 · 72 citations

Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis

Paula L. Jacobsen, Atul R. Mahableshwarkar, William Palo et al. · CNS Spectrums · 2015 · 68 citations · Full text